VYOME HOLDINGS, INC. Assets, Fair Value Disclosure
VYOME HOLDINGS, INC. (HIND) had Assets, Fair Value Disclosure of $5.51 million as of 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2020-11-06
- 2020-09-30: Assets, Fair Value Disclosure $5.51M.
- 2020-06-30: Assets, Fair Value Disclosure $6.80M.
- 2020-03-31: Assets, Fair Value Disclosure $8.91M.
- 2019-12-31: Assets, Fair Value Disclosure $14.05M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2020-09-30 | $5.51M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $6.80M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $8.91M 10-Q · filed 2020-06-19 |
| 2019-12-31 | $14.05M 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |